Publications by authors named "A N Toukap"
Objective: This literature review aimed to identify the most efficacious current interventions for dactylitis and provide up-to-date scientific evidence to support the 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) recommendations on the management of psoriatic arthritis.
Methods: Original articles published from 2013 to 2020, registered in MEDLINE, Embase, and Cochrane Library, describing interventional trials and reporting dactylitis-related outcomes were included. The 20 members of the GRAPPA dactylitis group were divided into 9 subgroups according to treatment, and members of each group independently extracted data from articles/abstracts corresponding to their group by using a standardized data extraction form.
Introduction: Apremilast is approved for the treatment of psoriasis and psoriatic arthritis (PsA). Real-world evidence on the efficacy and safety of apremilast in clinical practice is limited. We assessed the use of apremilast in patients with PsA in Belgium clinical practice.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to characterize the types and severity of Psoriatic Arthritis (PsA) and its impact on patients' quality of life.
- A longitudinal observational study was conducted with 461 PsA patients over 2 years, collecting demographic, clinical, and patient-reported data through three scheduled visits.
- Findings revealed that many patients still experienced disease activity and burden despite treatments, with 73.5% having combined joint involvement and a significant portion of patients reporting active disease symptoms.